BR9908480A - Compostos heterocìclicos como inibidores de enzimas rotamase - Google Patents
Compostos heterocìclicos como inibidores de enzimas rotamaseInfo
- Publication number
- BR9908480A BR9908480A BR9908480-5A BR9908480A BR9908480A BR 9908480 A BR9908480 A BR 9908480A BR 9908480 A BR9908480 A BR 9908480A BR 9908480 A BR9908480 A BR 9908480A
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- heterocyclic compounds
- rotamase
- compounds
- enzymes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Patente de Invenção: <B>"COMPOSTOS HETEROCìCLICOS COMO INIBIDORES DE ENZIMAS ROTAMASE"<D>. Compostos da fórmula: em que R¹, Y, W, A e R² são conforme definidos na Descrição, são inibidores de enzimas rotamase, em particular FKBP-12 e FKBP-52. Os compostos, por conseguinte, moderam a regeneração e protuberância neuronais e podem ser usados para o tratamento de distúrbios neurológicos provenientes de doenças neurodegenerativas e lesão no nervo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9804426.6A GB9804426D0 (en) | 1998-03-02 | 1998-03-02 | Heterocycles |
PCT/IB1999/000259 WO1999045006A1 (en) | 1998-03-02 | 1999-02-15 | Heterocyclic compounds as inhibitors of rotamase enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9908480A true BR9908480A (pt) | 2000-12-05 |
Family
ID=10827859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9908480-5A BR9908480A (pt) | 1998-03-02 | 1999-02-15 | Compostos heterocìclicos como inibidores de enzimas rotamase |
Country Status (20)
Country | Link |
---|---|
US (1) | US6610707B1 (pt) |
EP (1) | EP1060178B1 (pt) |
JP (1) | JP3668133B2 (pt) |
AP (1) | AP9901479A0 (pt) |
AR (1) | AR015528A1 (pt) |
AT (1) | ATE248836T1 (pt) |
AU (1) | AU2181099A (pt) |
BR (1) | BR9908480A (pt) |
CA (1) | CA2322442A1 (pt) |
CO (1) | CO4790154A1 (pt) |
DE (1) | DE69910984T2 (pt) |
DK (1) | DK1060178T3 (pt) |
ES (1) | ES2204101T3 (pt) |
GB (1) | GB9804426D0 (pt) |
GT (1) | GT199900029A (pt) |
MA (1) | MA26611A1 (pt) |
PA (1) | PA8468501A1 (pt) |
PT (1) | PT1060178E (pt) |
TN (1) | TNSN99031A1 (pt) |
WO (1) | WO1999045006A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338976B1 (en) * | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
US7265150B1 (en) * | 1998-08-14 | 2007-09-04 | Gpi Nil Holdings Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders |
US6284779B1 (en) | 1999-02-03 | 2001-09-04 | Schering Aktiiengesellschaft | Heteroaromatic compounds |
AU5483500A (en) | 1999-07-09 | 2001-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
US6323215B1 (en) | 1999-07-09 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
CA2379149A1 (en) | 1999-07-09 | 2001-01-18 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
DOP2000000107A (es) * | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas |
US6589978B2 (en) | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
BR0114836A (pt) | 2000-10-20 | 2003-07-01 | Pfizer Prod Inc | Agonistas de receptores beta-3 adrenérgicos e suas aplicações |
US20040171614A1 (en) * | 2002-02-06 | 2004-09-02 | Schering-Plough Corporation | Novel gamma secretase inhibitors |
US7256186B2 (en) | 2002-02-06 | 2007-08-14 | Schering Corporation | Gamma secretase inhibitors |
TW200302717A (en) | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
AU2003209527A1 (en) | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
AU2003248352A1 (en) | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | PROCESSES AND INTERMEDIATES USEFUL IN PREPARING Beta3-ADRENERGIC RECEPTOR AGONISTS |
EP1581213A4 (en) * | 2002-12-18 | 2008-11-19 | Cytovia Inc | 3,5-DISUBSTITUES-1,2,4-OXADIAZOLES AND ANALOGS AS ACTIVATORS OF CASPASES AND APOPTOSIS PROMOTERS, AND USE THEREOF |
WO2004096810A1 (en) | 2003-04-29 | 2004-11-11 | Pfizer Limited | 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension |
US7572799B2 (en) | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
WO2005097799A1 (en) | 2004-04-07 | 2005-10-20 | Pfizer Limited | Pyrazolo`4,3-d! pyrimidines |
US7829589B2 (en) * | 2005-06-10 | 2010-11-09 | Elixir Pharmaceuticals, Inc. | Sulfonamide compounds and uses thereof |
CA2611493A1 (en) * | 2005-06-10 | 2006-12-21 | Elixir Pharmaceuticals, Inc. | Sulfonamide compounds and uses thereof |
TW200833323A (en) | 2006-12-20 | 2008-08-16 | Taisho Pharmaceutical Co Ltd | Prophylactic or therapeutic agent for alopecia |
WO2011098451A1 (en) | 2010-02-10 | 2011-08-18 | Glaxosmithkline Llc | Purine derivatives and their pharmaceutical uses |
TWI534142B (zh) | 2011-03-15 | 2016-05-21 | 大正製藥股份有限公司 | Azole derivatives |
JP6020396B2 (ja) * | 2012-09-12 | 2016-11-02 | 大正製薬株式会社 | アゾール誘導体を含有する医薬 |
EP3650447A1 (en) * | 2018-11-08 | 2020-05-13 | Universite de Nantes | New selective modulators of insect nicotinic acetylcholine receptors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55153763A (en) * | 1979-05-21 | 1980-11-29 | Kyowa Hakko Kogyo Co Ltd | Modifier for citrus fruits |
MX9202466A (es) * | 1991-05-24 | 1994-06-30 | Vertex Pharma | Compuestos inmunosupresores novedosos. |
US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
TW401408B (en) | 1995-07-21 | 2000-08-11 | Fujisawa Pharmaceutical Co | Heterocyclic compounds having prostaglandin I2 agonism |
US5874449A (en) * | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
CN1295561A (zh) * | 1998-06-03 | 2001-05-16 | Gpinil控股公司 | N-杂环羧酸或羧酸等排物的n-结合氨磺酰 |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
-
1998
- 1998-03-02 GB GBGB9804426.6A patent/GB9804426D0/en not_active Ceased
-
1999
- 1999-02-15 EP EP99901847A patent/EP1060178B1/en not_active Expired - Lifetime
- 1999-02-15 PT PT99901847T patent/PT1060178E/pt unknown
- 1999-02-15 DE DE69910984T patent/DE69910984T2/de not_active Expired - Fee Related
- 1999-02-15 WO PCT/IB1999/000259 patent/WO1999045006A1/en active IP Right Grant
- 1999-02-15 JP JP2000534548A patent/JP3668133B2/ja not_active Expired - Fee Related
- 1999-02-15 AU AU21810/99A patent/AU2181099A/en not_active Abandoned
- 1999-02-15 BR BR9908480-5A patent/BR9908480A/pt not_active Application Discontinuation
- 1999-02-15 DK DK99901847T patent/DK1060178T3/da active
- 1999-02-15 ES ES99901847T patent/ES2204101T3/es not_active Expired - Lifetime
- 1999-02-15 AT AT99901847T patent/ATE248836T1/de not_active IP Right Cessation
- 1999-02-15 CA CA002322442A patent/CA2322442A1/en not_active Abandoned
- 1999-02-15 US US09/380,427 patent/US6610707B1/en not_active Expired - Fee Related
- 1999-02-25 AP APAP/P/1999/001479A patent/AP9901479A0/en unknown
- 1999-02-26 AR ARP990100828A patent/AR015528A1/es unknown
- 1999-02-26 GT GT199900029A patent/GT199900029A/es unknown
- 1999-03-01 TN TNTNSN99031A patent/TNSN99031A1/fr unknown
- 1999-03-01 MA MA25479A patent/MA26611A1/fr unknown
- 1999-03-01 PA PA19998468501A patent/PA8468501A1/es unknown
- 1999-03-02 CO CO99012808A patent/CO4790154A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1060178B1 (en) | 2003-09-03 |
MA26611A1 (fr) | 2004-12-20 |
DK1060178T3 (da) | 2003-11-24 |
WO1999045006A1 (en) | 1999-09-10 |
JP3668133B2 (ja) | 2005-07-06 |
DE69910984T2 (de) | 2004-07-15 |
ES2204101T3 (es) | 2004-04-16 |
CO4790154A1 (es) | 1999-05-31 |
CA2322442A1 (en) | 1999-09-10 |
GB9804426D0 (en) | 1998-04-29 |
US6610707B1 (en) | 2003-08-26 |
EP1060178A1 (en) | 2000-12-20 |
AU2181099A (en) | 1999-09-20 |
AP9901479A0 (en) | 1999-03-31 |
PA8468501A1 (es) | 2000-09-29 |
DE69910984D1 (de) | 2003-10-09 |
TNSN99031A1 (fr) | 2005-11-10 |
GT199900029A (es) | 2000-08-19 |
ATE248836T1 (de) | 2003-09-15 |
AR015528A1 (es) | 2001-05-02 |
PT1060178E (pt) | 2003-12-31 |
JP2002505329A (ja) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908480A (pt) | Compostos heterocìclicos como inibidores de enzimas rotamase | |
BR9912330A (pt) | Compostos heterocìclicos como inibidores de enzimas rotamase | |
BR9811685A (pt) | Derivados de piridina | |
BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
WO2005009349A3 (en) | Composition and method for treating neurological disorders | |
YU21702A (sh) | Supstituisani indoli za moduliranje nfkb aktivnosti | |
BR0009167A (pt) | Inibidores de enzima impdh | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
BR0016195A (pt) | 4-pirimidinil-n-acil-l-fenilalaninas | |
MY138140A (en) | N-aroylphenylalanine derivatives | |
BR9812699A (pt) | Derivados de benzamidina | |
BR0012666A (pt) | Imidazoimidazóis e triazóis como agentes anti-inflamatórios | |
BR0008958A (pt) | Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc | |
ZA200005217B (en) | α-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders. | |
ATE490786T1 (de) | Behandlung von verletzungen des zentralen nervensystems | |
BR0313265A (pt) | Compostos e respectivos processos de preparação, uso e formulações farmacêuticas e métodos de prevenção e/ou tratamento de distúrbios mediados por receptor mglur5 e de inbição da ativação de receptores mglu r5. | |
ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
BR0015254A (pt) | Derivados de carbamoiloxialquil-azólio substituìdos em n | |
NZ514037A (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders | |
NO20052153L (no) | Piperazin- og piperidinderivater for behandling av nevrologiske sykdommer. | |
BR9916324A (pt) | 4,5-pirazinoxindóis como inibidores de proteìna quinase | |
BR9713207A (pt) | Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
BR9811348A (pt) | Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas. | |
BR9808923A (pt) | Composto, e, processo para fazer o mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 24 E 25 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |